Trade Names:
Status: Approved
Entry Type: Small molecule
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Cerebral Palsy; Dyskinesias Phase 3 ClinicalTrials

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Nervous system disorders
23.0
Psychiatric disorders
21.8
General disorders and administration site conditions
15.33
Injury, poisoning and procedural complications
8.25
Musculoskeletal and connective tissue disorders
4.97
Gastrointestinal disorders
4.54
Respiratory, thoracic and mediastinal disorders
3.25
Cardiac disorders
2.77
Vascular disorders
2.77
Investigations
2.57
Skin and subcutaneous tissue disorders
2.03